|
Powered by Cell Signaling Technology |
Site Information |
---|
GQSQGPPtPPtTPKT SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 40722389 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Kinases, in vitro: |
Downstream Regulation | |
---|---|
Effects of modification on SOX9: | |
Effects of modification on biological processes: | |
Induce interaction with: |
References | |
---|---|
Suryo Rahmanto A, et al. (2016) FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. EMBO J 35, 2192-2212
27625374 Curated Info |
|
Hong X, et al. (2016) SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Res 44, 8855-8869
27566146 Curated Info |
|
Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275 Curated Info |
|
Yi T, et al. (2014) Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells. Proc Natl Acad Sci U S A 111, E2182-90
24782546 Curated Info |